Risk of transmission of infections to others after donor-derived infection transmissions [0.03%]
感染捐献者衍生感染后向他人传播的风险
Ines Ushiro-Lumb,Douglas Thorburn
Ines Ushiro-Lumb
Oral vancomycin for Clostridioides difficile prophylaxis in allogenic hematopoietic cell transplant [0.03%]
口服万古霉素用于异基因造血细胞移植患者预防艰难梭菌感染
Olivia J Altemeier,Kelsey T Konrardy
Olivia J Altemeier
Background: Neutropenia and antibiotic use put patients at risk for Clostridioides difficile infection (CDI) following allogenic hematopoietic cell transplant (alloHCT). CDI following alloHCT has been associated with acut...
Evaluation of cytomegalovirus "Blips" in high-risk kidney/kidney-pancreas transplant recipients [0.03%]
评估高危受者肾/胰肾移植术后人类巨细胞病毒载量波动现象
Alexandra T Payne,Brian K Lindner,Alexander J Gilbert et al.
Alexandra T Payne et al.
Background: Cytomegalovirus (CMV) is a significant cause of morbidity and mortality after solid organ transplantation. While guidelines suggest using highly sensitive QNAT assays for CMV detection, there is no defined vir...
An approach to COVID-19 vaccination hesitance in an academic transplant center [0.03%]
移植中心COVID-19疫苗接种犹豫应对策略的一例分析
A Scott Lea,Katie Kirk,Michael Kueht et al.
A Scott Lea et al.
QuantiFERON-cytomegalovirus to predict clinically significant cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation [0.03%]
通过allo-HSCT后预测临床意义的巨细胞病毒感染的QuantiFERON-巨细胞病毒检测
Grace Thompson,Peter Boan,Duncan Purtill et al.
Grace Thompson et al.
Background: Controlling cytomegalovirus (CMV) infection through prophylaxis or pre-emptive therapy remains an important contributor to outcomes after allogeneic hematopoetic stem cell transplant (alloHCT). Predicting clin...
Ways to boost cellular immunity in solid organ transplant recipients - The case of letermovir [0.03%]
固体器官移植受者的细胞免疫增强方法——莱特莫韦的例子
Amina Abu-Omar,Martina Sester
Amina Abu-Omar
Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients [0.03%]
2019冠状病毒病疫苗对实体器官移植受者临床疾病的保护效果
Saima Aslam,Jinyuan Liu,Rachel Sigler et al.
Saima Aslam et al.
Background: Clinical effectiveness of coronavirus disease 2019 (COVID-19) vaccination in solid organ transplant recipients (SOTRs) is not well documented despite multiple studies demonstrating sub-optimal immunogenicity. ...
Prevalence of carbapenemase-producing organisms among hospitalized solid organ transplant recipients, five US hospitals, 2019-2020 [0.03%]
美国五家医院住院固体器官移植受者中产碳青霉烯酶型病原体的流行率，2019-2020年
June L Chan,Elizabeth Nazarian,Kimberlee A Musser et al.
June L Chan et al.
Background: Passive reporting to the Centers for Disease Control and Prevention has identified carbapenemase-producing organisms (CPOs) among solid organ transplant (SOT) recipients, potentially representing an emerging s...
An outbreak of SARS-CoV-2 on a transplant unit in the early vaccination era [0.03%]
新冠疫苗接种初期移植病房出现新冠肺炎疫情
Scott C Roberts,Carlo Foppiano Palacios,Nathan D Grubaugh et al.
Scott C Roberts et al.
Background: Solid organ transplant recipients are at increased risk of COVID-19-associated morbidity and mortality. Aims: We describe a...
Characteristics and outcomes among vaccinated lung transplant patients with breakthrough COVID-19 [0.03%]
突破性新冠肺炎肺移植患者的特点和结局特征
Srinivas Bollineni,Luke D Mahan,Patrick Duncan et al.
Srinivas Bollineni et al.
Background: Despite multiple studies evaluating the immunological responsiveness to vaccines, the clinical effectiveness of the two-dose mRNA vaccine schedule among lung transplant (LT) patients has not been evaluated. ...